Detalhe da pesquisa
1.
Targeted Nanoparticle for Co-delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2+ Breast Cancer: Efficacy in Breast Tumor and Brain Metastasis.
Small
; 18(11): e2107550, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35083840
2.
Analysis of acquired resistance to metronomic oral topotecan chemotherapy plus pazopanib after prolonged preclinical potent responsiveness in advanced ovarian cancer.
Angiogenesis
; 17(3): 661-73, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24569856
3.
Preclinical approaches to study the biology and treatment of brain metastases.
Semin Cancer Biol
; 21(2): 123-30, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21147227
4.
Ang2 inhibitors and Tie2 activators: potential therapeutics in perioperative treatment of early stage cancer.
EMBO Mol Med
; 13(7): e08253, 2021 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34125494
5.
Metronomic chemotherapy offsets HIFα induction upon maximum-tolerated dose in metastatic cancers.
EMBO Mol Med
; 12(9): e11416, 2020 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32686360
6.
Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer.
NPJ Breast Cancer
; 6: 29, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32704531
7.
Suppressive impact of metronomic chemotherapy using UFT and/or cyclophosphamide on mediators of breast cancer dissemination and invasion.
PLoS One
; 14(9): e0222580, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31536574
8.
The role of tissue inhibitors of metalloproteinases in tumorigenesis and metastasis.
Crit Rev Clin Lab Sci
; 45(3): 291-338, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18568853
9.
Pharmacodynamic and pharmacokinetic study of chronic low-dose metronomic cyclophosphamide therapy in mice.
Mol Cancer Ther
; 6(8): 2280-9, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17671082
10.
PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis.
Clin Cancer Res
; 21(9): 2138-47, 2015 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25316811
11.
Neoadjuvant antiangiogenic therapy reveals contrasts in primary and metastatic tumor efficacy.
EMBO Mol Med
; 6(12): 1561-76, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25361689
12.
Roles for endothelin receptor B and BCL2A1 in spontaneous CNS metastasis of melanoma.
Cancer Res
; 72(19): 4909-19, 2012 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22865454
13.
Mouse models of advanced spontaneous metastasis for experimental therapeutics.
Nat Rev Cancer
; 11(2): 135-41, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21258397
14.
Potent preclinical impact of metronomic low-dose oral topotecan combined with the antiangiogenic drug pazopanib for the treatment of ovarian cancer.
Mol Cancer Ther
; 9(4): 996-1006, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20371722
15.
Effective treatment of advanced human melanoma metastasis in immunodeficient mice using combination metronomic chemotherapy regimens.
Clin Cancer Res
; 15(15): 4867-74, 2009 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19622578
16.
Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis.
Cancer Cell
; 15(3): 232-9, 2009 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-19249681
17.
Development of a preclinical model of spontaneous human melanoma central nervous system metastasis.
Cancer Res
; 68(12): 4500-5, 2008 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18559492
18.
Development and characterization of a clinically relevant mouse model of melanoma brain metastasis.
Pigment Cell Melanoma Res
; 26(5): 743-5, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23647875